Posttraumatic Stress Disorder Checklist (PCL-5)

Abstract

The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) is an internationally recognized, 20-item self-report psychometric instrument engineered to assess the presence and severity of posttraumatic stress disorder (PTSD) symptoms in adults aged 18 years and older, corresponding directly to the diagnostic criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5; American Psychiatric Association [APA], 2013). Developed by senior psychometricians and traumatic stress investigators at the National Center for PTSD, the PCL-5 operationalizes the four core DSM-5 PTSD symptom clusters: Criterion B (Intrusions), Criterion C (Avoidance), Criterion D (Negative Alterations in Cognitions and Mood), and Criterion E (Alterations in Arousal and Reactivity). Respondents rate each symptom on a 5-point Likert scale ranging from 0 (“Not at all”) to 4 (“Extremely”) based on their experiences over the preceding month, yielding a continuous total symptom severity score between 0 and 80, alongside subscale cluster severity metrics. Empirical investigations demonstrate exceptional psychometric properties across clinical, military, veteran, and civilian trauma-exposed populations, characterized by elevated internal consistency (Cronbach’s α and McDonald’s ω typically ranging between .94 and .96), robust test-retest reliability (r = .82 to .88 across 1- to 2-week intervals), and rigorous convergent validity with structured clinical interviews, including the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) (r ≥ .85). Confirmatory factor analytic investigations consistently demonstrate that while the DSM-5 four-factor model provides adequate fit, alternative structural configurations—most notably the six-factor Anhedonia model and the seven-factor Hybrid model (Armour et al., 2015)—frequently yield superior statistical indices, clarifying the phenotypic heterogeneity of trauma reactions. The PCL-5 serves three distinct clinical and research functions: screening trauma-exposed individuals, monitoring longitudinal symptom trajectories and treatment outcomes, and provisional diagnostic categorization utilizing established empirical cut-off thresholds (typically 31–33) or cluster-specific diagnostic algorithms. Available in the public domain for research and clinical use without licensing fees, the instrument stands as an indispensable cornerstone in contemporary psychotraumatology.

Keywords

Posttraumatic Stress Disorder, PCL-5, Psychometrics, Trauma Assessment, DSM-5, Diagnostic Accuracy, Intrusive Memories, Avoidance, Negative Cognitions, Hyperarousal, Measurement Invariance, Confirmatory Factor Analysis

Authors

The Posttraumatic Stress Disorder Checklist for DSM-5 was developed by a team of clinical psychologists and psychometricians affiliated with the United States Department of Veterans Affairs (VA) National Center for PTSD:

• Frank W. Weathers, Ph.D. — Department of Psychology, Auburn University, Auburn, Alabama, USA.
• Brett T. Litz, Ph.D. — Behavioral Science Division, National Center for PTSD, VA Boston Healthcare System; Department of Psychiatry, Boston University School of Medicine, Boston, Massachusetts, USA.
• Terence M. Keane, Ph.D. — Behavioral Science Division, National Center for PTSD, VA Boston Healthcare System; Department of Psychiatry, Boston University School of Medicine, Boston, Massachusetts, USA.
• Patrick A. Palmieri, Ph.D. — Center for the Treatment and Study of Traumatic Stress, Summa Health System, Akron, Ohio, USA.
• Brian P. Marx, Ph.D. — Behavioral Science Division, National Center for PTSD, VA Boston Healthcare System; Department of Psychiatry, Boston University School of Medicine, Boston, Massachusetts, USA.
• Paula P. Schnurr, Ph.D. — Executive Division, National Center for PTSD, White River Junction, Vermont; Department of Psychiatry, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.

Correspondence regarding the instrument and its programmatic updates is coordinated through the National Center for PTSD, Department of Veterans Affairs, 215 North Main Street, White River Junction, VT 05009, USA (Website: www.ptsd.va.gov).

Purpose

The primary clinical and psychometric objective of the PCL-5 is to provide an empirically validated, cost-effective, and standardized self-report measurement of posttraumatic stress symptom burden in accordance with the updated conceptualization of PTSD established in the DSM-5. In the transition from DSM-IV to DSM-5, the American Psychiatric Association reclassified PTSD, moving it out of the Anxiety Disorders category and establishing a dedicated diagnostic classification: Trauma- and Stressor-Related Disorders. This nosological shift reflected mounting clinical and neurobiological evidence indicating that PTSD encompasses not merely fear- and anxiety-based symptoms, but also profound affective blunting, pervasive cognitive alterations, dysphoria, anhedonia, dissociative phenomena, and externalizing behavioral trajectories such as irritability and recklessness. Consequently, the original PTSD Checklist (encompassing the PCL-M for military, PCL-C for civilian, and PCL-S for specific trauma variants) required substantial structural revision to accommodate the expansion from a three-cluster, 17-symptom configuration to a four-cluster, 20-symptom framework.

The operational purpose of the PCL-5 centers on three foundational applications:

• Standardized Clinical Screening: In primary care, community mental health clinics, emergency departments, and specialized veteran care facilities, the PCL-5 functions as an initial triage instrument. It detects clinically elevated posttraumatic stress reactions among individuals exposed to catastrophic physical, sexual, combat-related, interpersonal, or occupational trauma. A designated cut-off score identifies individuals requiring comprehensive, multi-method diagnostic appraisal, such as the gold-standard Clinician-Administered PTSD Scale (CAPS-5).
• Longitudinal Treatment Monitoring and Outcome Evaluation: The PCL-5 demonstrates high sensitivity to therapeutic change, making it a critical tool for measurement-based care. When administered repeatedly over the course of evidence-based trauma-focused psychotherapies—such as Prolonged Exposure (PE), Cognitive Processing Therapy (CPT), and Eye Movement Desensitization and Reprocessing (EMDR)—or pharmacotherapeutic trials, the scale quantifies symptom reduction. Research has established the Reliable Change Index (RCI) and minimal clinically important difference (MCID) for the PCL-5, permitting clinicians to distinguish genuine therapeutic progress from random measurement error.
• Provisional Diagnostic Formulation: While definitive psychiatric diagnosis necessitates a structured clinical interview to evaluate functional impairment, medical rule-outs, and differential diagnoses, the PCL-5 can generate a provisional or presumptive PTSD diagnosis. This is achieved either by applying validated empirical score cutoffs or by implementing a symptom-scoring algorithm that emulates the DSM-5 diagnostic rule (requiring at least one Criterion B symptom, one Criterion C symptom, two Criterion D symptoms, and two Criterion E symptoms endorsed at a moderate severity threshold or higher).

Furthermore, the PCL-5 addresses varied research paradigms. It enables epidemiological studies investigating the population-level prevalence of posttraumatic stress, mechanistic investigations tracking neuroendocrine and functional neuroimaging correlates of specific trauma symptom dimensions, and randomized clinical trials evaluating psychiatric or psychological interventions.

Psychological Construct

The latent psychological construct assessed by the PCL-5 is Posttraumatic Stress Disorder as operationalized by the DSM-5. This multidimensional construct conceptualizes PTSD as a complex systemic psychological, cognitive, and neurobiological reaction triggered by exposure to actual or threatened death, serious injury, or sexual violence (Criterion A). Rather than viewing trauma sequelae as a homogenous anxiety state, the DSM-5 construct spans 20 distinct cognitive, affective, behavioral, and physiological symptoms organized into four correlated but distinct symptom clusters:

Criterion B: Intrusion Symptoms (Items 1–5)

Intrusion symptoms capture the involuntary, recurrent re-experiencing of the traumatic event, reflecting deficits in autobiographical memory consolidation and fear extinction. This cluster captures:

• Recurrent, involuntary, and intrusive distressing memories: Spontaneous cognitive intrusions that disrupt current conscious activity (Item 1).
• Recurrent distressing dreams: Traumatic nightmares whose content or affective tone is linked directly to the event (Item 2).
• Dissociative reactions (e.g., flashbacks): Sensory and perceptual phenomena wherein the patient experiences a subjective re-enactment of the trauma, ranging on a continuum from transient sensory distortions to complete loss of current environmental awareness (Item 3).
• Intense or prolonged psychological distress: Acute affective reactivity triggered by internal cues (e.g., emotional states, somatic sensations) or external cues (e.g., sights, sounds, anniversaries) resembling aspects of the trauma (Item 4).
• Marked physiological reactivity: Autonomic hyperarousal, including tachycardia, hyperventilation, diaphoresis, and muscular bracing, elicited upon encountering trauma-related reminders (Item 5).

Criterion C: Avoidance Symptoms (Items 6–7)

Avoidance constitutes a core maintaining factor of PTSD within behavioral and cognitive models, sustained through negative reinforcement mechanisms. The DSM-5 delineates two primary forms of avoidance:

• Internal Avoidance: Active behavioral and cognitive efforts to evade distressing memories, thoughts, ruminations, or emotional states directly linked to the traumatic incident (Item 6).
• External Avoidance: Systematic evasion of environmental reminders, such as specific individuals, physical locations, conversational topics, sensory cues, activities, or contextual situations that trigger recollection of the trauma (Item 7).

Criterion D: Negative Alterations in Cognitions and Mood (Items 8–14)

Criterion D reflects a significant expansion beyond previous DSM editions, recognizing that pervasive disruptions in posttraumatic cognitive appraisals and emotional functioning form a distinct core dimension of the disorder:

• Inability to remember important aspects of the trauma: Psychogenic or dissociative amnesia regarding central features of the event, distinct from head injury or substance intoxication (Item 8).
• Persistent and exaggerated negative beliefs and expectations: Overgeneralized negative schemas regarding oneself, others, or the world at large (e.g., “I am irreparably damaged,” “No one can be trusted,” “The world is entirely lethal”; Item 9).
• Persistent, distorted cognitions about etiology: Cognitive misattributions causing inappropriate self-blame or the blaming of others regarding the causation or outcomes of the trauma (Item 10).
• Persistent negative emotional state: Chronic elevated baseline levels of negative affect, including intense fear, horror, rage, guilt, or humiliation (Item 11).
• Markedly diminished interest or participation: Severe loss of engagement with significant vocational, recreational, or social pursuits (Item 12).
• Feelings of detachment or estrangement: Interpersonal alienation and an inability to maintain psychological closeness or relational intimacy with others (Item 13).
• Persistent inability to experience positive emotions: Anhedonia characterized by emotional numbing and the inability to feel joy, affection, satisfaction, or peace (Item 14).

Criterion E: Alterations in Arousal and Reactivity (Items 15–20)

Criterion E reflects baseline hyperarousal and neurobiological dysregulation, typically mediated by alterations in the sympathetic-adrenomedullary axis and hypothalamic-pituitary-adrenal (HPA) axis:

• Irritable behavior and angry outbursts: Verbal or physical aggression directed against people or objects with little or no provocation (Item 15).
• Reckless or self-destructive behavior: High-risk activities, dangerous driving, substance abuse, or self-harming behaviors (Item 16, a novel addition in DSM-5).
• Hypervigilance: Pervasive environmental scanning, enhanced threat anticipation, and guardedness (Item 17).
• Exaggerated startle response: Motoric hypersensitivity to sudden acoustic or tactile stimuli (Item 18).
• Problems with concentration: Attentional deficits, executive working memory disruption, and high distractibility (Item 19).
• Sleep disturbance: Insomnia characterized by initial sleep-onset latency, frequent nocturnal awakenings, or unrefreshing sleep architecture (Item 20).

Theoretical Framework

The structural and conceptual architecture of the PCL-5 is grounded in contemporary psychophysiological, cognitive, and behavioral theories of traumatic stress. Four primary theoretical frameworks underpin the operationalization of the items:

1. Emotional Processing Theory

Formulated by Edna B. Foa and Michael J. Kozak (1986), and subsequently refined by Foa, Huppert, and Cahill (2006), Emotional Processing Theory (EPT) posits that PTSD arises from the formation of a pathological “fear network” in long-term memory. This associative memory structure contains information regarding:

• Stimulus elements of the trauma (e.g., dark alleys, the sound of a vehicle engine, somatic sensations).
• Physiological and behavioral responses to the event (e.g., accelerated heart rate, muscle tension, screaming).
• Meaning elements that link stimulus characteristics to response meaning (e.g., “the world is dangerous,” “my reactions imply personal vulnerability”).

In individuals with PTSD, this network exhibits a low activation threshold, causing benign cues to reactivate the entire network and trigger intrusive phenomena (Criterion B) and autonomic arousal (Criterion E). Because individuals attempt to escape this distressing state through cognitive and behavioral avoidance (Criterion C), corrective cognitive-affective information cannot be incorporated, preventing habituation and fear extinction. The PCL-5 measures each component of this network: fear elicitation (Items 4–5), cognitive/behavioral evasion (Items 6–7), and chronic autonomic hyper-reactivity (Items 17–18).

2. Cognitive Model of PTSD

Developed by Anke Ehlers and David M. Clark (2000), this cognitive model addresses why trauma memories fail to integrate into normal autobiographical memory. The authors propose that persistent PTSD occurs when individuals process the trauma and its aftermath in a manner that creates a sense of imminent, continuous threat. This ongoing threat is generated by two interrelated mechanisms:

• Negative Appraisals of the Trauma and Its Sequelae: Catastrophic interpretations of the event itself (e.g., overestimating likelihood of harm) or post-event symptoms (e.g., viewing normal intrusions as signs of impending insanity). This directly aligns with the expanded Criterion D symptoms of the PCL-5 (Items 9 and 10).
• Nature of the Trauma Memory: Poor intentional recall of central events (Item 8) contrasted with robust perceptual priming and involuntary cue-driven retrieval (Items 1–3). Intrusive memories occur because sensory features of the trauma are poorly integrated into their spatio-temporal narrative context.

3. Dual Representation Theory

Advanced by Chris R. Brewin and colleagues (1996, 2010), Dual Representation Theory (DRT) posits that trauma exposure leads to dual memory traces operating through distinct neural substrates:

• Verbally Accessible Memory (VAM): Consciously retrievable, autobiographically integrated memories processed by the hippocampus and neocortex.
• Situationally Accessible Memory (SAM): Perceptually bound, sensory representations processed directly via subcortical circuits (primarily the amygdala) without full hippocampal contextualization.

Under extreme stress, heightened neuroendocrine surges impair hippocampal processing, impeding the VAM system while enhancing the lower-level sensory encoding of the SAM system. Consequently, the patient experiences vivid, uncontextualized flashbacks and intrusive imagery (Items 1, 3, and 5) that lack temporal demarcation, while simultaneously experiencing deficits in coherent, deliberate episodic recall (Item 8).

4. Contemporary Neurobiological and Circuitry Models

Neuroimaging and neurobiological literature demonstrates that PTSD represents systemic dysregulation within fronto-limbic neural networks. Specifically, structural and functional MRI investigations identify a triad of interconnected regions underlying the clinical presentation:

• Hyper-reactivity of the Amygdala and Insula: Directly correlates with heightened autonomic hyperarousal, exaggerated acoustic startle responses, and fear conditioning (Criterion B and E).
• Hypo-activation and Volumetric Reductions in the Medial Prefrontal Cortex (mPFC) and Anterior Cingulate Cortex (ACC): Results in structural failure of top-down inhibitory control over subcortical limbic regions, preventing fear extinction and facilitating persistent dysphoric affect (Criterion D).
• Structural and Functional Alterations of the Hippocampus: Leads to impaired contextual processing, failure to recognize safety signals, and fragmentation of explicit memory recall (Criterion B and Item 8).

Validity

Extensive psychometric evaluations have systematically substantiated the validity of the PCL-5 across diverse clinical, military, and epidemiological cohorts.

Construct Validity

Construct validity has been verified using both exploratory and confirmatory factor analysis across multiple populations, confirming that the 20 items converge onto the latent construct of PTSD as delineated by modern nosological frameworks. Multitrait-multimethod matrices and structural equation modeling confirm that the individual items demonstrate high factor loadings (almost universally > .60, with most > .75) onto their respective subscales and higher-order constructs (Blevins et al., 2015; Wortmann et al., 2016).

Convergent Validity

The PCL-5 exhibits strong convergent validity when evaluated against established diagnostic benchmarks and concurrent self-report symptom inventories:

• Clinician-Administered PTSD Scale (CAPS-5): The PCL-5 total score correlates strongly with the CAPS-5 total symptom severity score across military service members (r = .85) and civilian populations (r = .86), confirming that self-reported severity aligns with expert clinical judgment (Weathers et al., 2018).
• Preceding Versions of the PCL: Correlations between the PCL-5 and the legacy PCL-C/PCL-M (DSM-IV) routinely exceed r = .90, demonstrating strong longitudinal continuity across diagnostic revisions while capturing expanded DSM-5 variance.
• Measures of Depressive and Anxiety Symptomatology: Moderately strong correlations are observed between the PCL-5 and related affective measures, such as the Patient Health Questionnaire-9 (PHQ-9) (r = .68 to .74) and the Beck Depression Inventory-II (BDI-II) (r = .70 to .76). These correlations are theoretically consistent with known rates of trauma-related mood dysregulation and affective comorbidity.

Discriminant Validity

Discriminant validity is supported by lower correlations between the PCL-5 and constructs conceptually distinct from posttraumatic stress:

• Correlations with general somatic distress and bodily pain (e.g., SF-36 physical functioning subscales) are low to moderate (r = .25 to .35).
• Correlations with measures of manic symptomatology, antisocial behavioral traits, or alcohol abuse indices (e.g., AUDIT) generally range between r = .20 and .35, indicating that the PCL-5 selectively isolates traumatic stress reactions from generalized, non-affective psychopathology.

Diagnostic Accuracy and Receiver Operating Characteristic (ROC) Analyses

Numerous ROC analyses have evaluated the diagnostic efficacy of the PCL-5 relative to structured clinical interview diagnoses (primarily CAPS-5). Across multiple civilian trauma samples, the Area Under the Curve (AUC) ranges from .92 to .97, indicating high diagnostic accuracy. In initial military validation cohorts (Blevins et al., 2015; Wortmann et al., 2016), a cut-off score of 33 produced optimal diagnostic efficiency, balancing sensitivity (.88) and specificity (.69). Subsequent investigations across diverse settings have identified optimal cut-off scores ranging between 31 and 33:

• Cut-off 31: Maximizes sensitivity (often > .90), making it ideal for primary care triage, general medical screening, and epidemiological surveys where minimizing false negatives is paramount.
• Cut-off 33: Yields a more conservative profile with elevated specificity, reducing false positives in specialized psychiatric settings, clinical trials, and disability determinations.

Reliability

The PCL-5 demonstrates robust psychometric reliability across internal consistency, temporal stability, and measurement error dimensions.

Internal Consistency

Investigations across civilian university cohorts, treatment-seeking military veterans, community survivors of interpersonal trauma, and international samples demonstrate high internal consistency:

• Total Scale: Cronbach’s alpha (α) coefficients for the 20-item composite score consistently range from .94 to .96, indicating strong item interrelatedness without functional redundancy. McDonald’s omega (ω), which provides a more accurate estimate of composite reliability under conditions of tau-inequivalence, similarly yields values between .95 and .97.
• Symptom Clusters (Subscales):
  • Criterion B (Intrusions, 5 items): α = .87 to .91.
  • Criterion C (Avoidance, 2 items): α = .82 to .86 (robust given that alpha is constrained by brief item length).
  • Criterion D (Negative Alterations in Cognitions/Mood, 7 items): α = .86 to .90.
  • Criterion E (Hyperarousal, 6 items): α = .84 to .88.

Test-Retest Reliability

The temporal stability of the PCL-5 has been evaluated across varying retest intervals:

• Brief Intervals (1 to 7 Days): In non-treatment-seeking samples assessed across a 1-week interval to minimize clinical state changes, the test-retest correlation coefficient was r = .88 (Blevins et al., 2015).
• Moderate Intervals (2 to 4 Weeks): Across a 30-day interval in clinically stable cohorts, stability coefficients remained elevated (r = .82 to .84), confirming the temporal stability of the construct in the absence of therapeutic intervention.

Standard Error of Measurement and Clinically Meaningful Change

Psychometric evaluations have established the Standard Error of Measurement (SEM) for the PCL-5 at approximately 3.1 to 3.6 points. Based on this, the Reliable Change Index (RCI) calculation indicates that a change of 5 to 10 points represents statistically reliable change beyond the bounds of measurement error. For clinical interventions, a reduction of 10 points is broadly accepted as representing a clinically meaningful response, whereas a reduction of 15 to 18 points indicates substantive symptom remission or resolution.

Factor Analysis

The structural dimensionality of the PCL-5 has been evaluated via Exploratory Structural Equation Modeling (ESEM) and Confirmatory Factor Analysis (CFA). These analyses have compared competing theoretical models of PTSD’s phenotypic architecture.

Competing Latent Structural Models

Investigators have evaluated multiple alternative factorial configurations:

• DSM-5 Four-Factor Model: Mirrors the official diagnostic criteria: Intrusion (items 1–5), Avoidance (items 6–7), Negative Alterations in Cognitions and Mood (items 8–14), and Hyperarousal (items 15–20). While demonstrating acceptable fit in empirical trials (CFI > .90, TLI > .89, RMSEA ≈ .06), it is often outperformed by more differentiated models.
• King et al. (1998) Four-Factor Emotional Numbing Model: Delineates Intrusion, Avoidance, Emotional Numbing (items 12–14), and Hyperarousal.
• Simms et al. (2002) Four-Factor Dysphoria Model: Isolates a broad general dysphoric factor containing negative cognitions, affective flattening, and non-fear hyperarousal symptoms, contrasting with specific fear-based trauma indicators.
• Armour et al. (2015) Seven-Factor Hybrid Model: This configuration decomposes the 20 items into seven correlated factors:
  1. Intrusion (Items 1–5)
  2. Avoidance (Items 6–7)
  3. Negative Affect (Items 8–11)
  4. Anhedonia (Items 12–14)
  5. Dysphoric Arousal (Items 19–20: concentration problems and sleep disturbance)
  6. Anxious Arousal (Items 17–18: hypervigilance and exaggerated startle)
  7. Externalizing Behavior (Items 15–16: irritability/aggression and reckless behavior)

Structural Fit Comparisons

Across extensive structural equation modeling investigations in both military veterans (Wortmann et al., 2016) and civilian trauma survivors (Armour et al., 2015; Ashbaugh et al., 2016), the Seven-Factor Hybrid Model and the closely related Six-Factor Anhedonia Model demonstrate superior model fit indices relative to the formal DSM-5 four-factor configuration. Typical goodness-of-fit indices reported across large cohorts (N > 1,000) show:

• DSM-5 Four-Factor Model: χ²/df = 4.12, Comparative Fit Index (CFI) = .918, Tucker-Lewis Index (TLI) = .907, Root Mean Square Error of Approximation (RMSEA) = .061, Standardized Root Mean Square Residual (SRMR) = .049.
• Armour Seven-Factor Hybrid Model: χ²/df = 2.45, CFI = .964, TLI = .955, RMSEA = .042 (90% CI [.038, .047]), SRMR = .033.

These findings indicate that separating hyperarousal into anxious arousal and dysphoric arousal, while distinguishing between threat-based avoidant behavior, emotional numbing/anhedonia, and externalizing behaviors, captures the multidimensionality of trauma sequelae more precisely.

Measurement Invariance

Metric and scalar measurement invariance of the PCL-5 has been confirmed across several demographic and clinical groups:

• Gender Invariance: Confirmed across male and female samples, ensuring that observed differences reflect true variations in symptom severity rather than differential item functioning (DIF).
• Civilian vs. Military Invariance: Confirmed across active-duty military cohorts, combat veterans, and non-military civilian trauma survivors.
• Cross-Cultural and Linguistic Invariance: Demonstrated across validated translations (including French, Spanish, Chinese, German, Arabic, and Swedish versions), showing consistent factor loadings across diverse cultural contexts.

Instrument / Measurement Tool

• Instrument Name: Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5)
• Instrument Type: Self-administered psychological assessment instrument / Self-report rating scale
• Construct Assessed: Posttraumatic Stress Disorder symptom severity and provisional diagnostic status according to DSM-5 criteria
• Target Population: Adults (aged 18 years and older) with confirmed or suspected lifetime exposure to DSM-5 Criterion A traumatic events
• Administration Time: Approximately 5 to 10 minutes
• Reading Level: 6th to 8th-grade reading level (Flesch-Kincaid Grade Level ≈ 6.8)
• Available Formats: Three primary standardized formats designed by the National Center for PTSD:
  • Format 1 (PCL-5 without Criterion A assessment): The 20 symptom items are administered with standard instructions referring to “the stressful experience.” This version is typically used when trauma exposure has already been verified via another validated instrument.
  • Format 2 (PCL-5 with Criterion A brief screen): Includes a brief introductory screening component that defines Criterion A, provides brief examples of traumatic stressors, and instructs the respondent to target their single worst index trauma.
  • Format 3 (PCL-5 with Life Events Checklist for DSM-5 [LEC-5]): Incorporates the comprehensive LEC-5 alongside an extended Criterion A evaluation section, assessing life-event exposure history directly before measuring past-month symptom severity.
• Number of Items: 20 items corresponding directly to the 20 DSM-5 PTSD symptoms
• Response Scale: 5-point Likert rating scale:
  • 0 = Not at all
  • 1 = A little bit
  • 2 = Moderately
  • 3 = Quite a bit
  • 4 = Extremely
• Scoring and Diagnostic Rules:
  • Total Continuous Symptom Severity Score: Calculated by summing all 20 items, producing a total score range from 0 to 80. Higher scores indicate greater PTSD symptom severity.
  • Symptom Cluster Subscale Scores: Derived by summing the respective items within each cluster:
    • Criterion B (Intrusions): Items 1–5 (Range: 0–20)
    • Criterion C (Avoidance): Items 6–7 (Range: 0–8)
    • Criterion D (Negative Alterations in Cognitions and Mood): Items 8–14 (Range: 0–28)
    • Criterion E (Arousal and Reactivity): Items 15–20 (Range: 0–24)
  • Provisional Diagnostic Algorithm: An item is considered endorsed if rated at 2 (“Moderately”) or higher. To qualify for a provisional diagnosis, the individual must endorse:
    • At least 1 Criterion B item (Items 1–5)
    • At least 1 Criterion C item (Items 6–7)
    • At least 2 Criterion D items (Items 8–14)
    • At least 2 Criterion E items (Items 15–20)
  • Total Score Cut-off Threshold: A total cut-off score between 31 and 33 indicates clinically significant PTSD symptomatology, warranting full diagnostic clinical interviewing (e.g., CAPS-5).

Permissions & Fee and Test Year

The Posttraumatic Stress Disorder Checklist for DSM-5 was completed and released into the clinical and academic domain in 2013 by the National Center for PTSD, following the release of the DSM-5. As a work produced by employees of the United States Federal Government (Department of Veterans Affairs), the PCL-5 resides in the public domain. There are no licensing fees, royalties, or commercial costs associated with acquiring, reproducing, or administering the PCL-5 for clinical care, educational instruction, or academic research.

Although the assessment is freely accessible via the National Center for PTSD website (www.ptsd.va.gov), professional testing standards dictate that interpretation and diagnostic formulation must be conducted by qualified healthcare professionals (such as licensed psychologists, psychiatrists, or clinical social workers) trained in psychometric assessment and psychiatric nosology. Modification of item wording, cluster structures, or scoring parameters is strongly discouraged, as alterations compromise the instrument’s established psychometric validity, normative comparability, and diagnostic utility.

References

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Publishing. https://doi.org/10.1176/appi.books.9780890425596

Armour, C., Tsai, J., Durham, T. A., Charak, R., Biehn, T. L., Elhai, J. D., & Pietrzak, R. H. (2015). Dimensional structure of DSM-5 posttraumatic stress symptoms: Support for a hybrid model in combat-exposed U.S. military veterans. Journal of Psychiatric Research, 61, 106–113. https://doi.org/10.1016/j.jpsychires.2014.10.012

Ashbaugh, A. R., Houle-Johnson, S., Herbert, C., El-Hage, W., & Brunet, A. (2016). Psychometric validation of the English and French versions of the Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5). PLOS ONE, 11(10), e0161645. https://doi.org/10.1371/journal.pone.0161645

Blevins, C. A., Weathers, F. W., Davis, M. T., Witte, T. K., & Domino, J. L. (2015). The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): Development and initial psychometric evaluation. Journal of Traumatic Stress, 28(6), 489–498. https://doi.org/10.1002/jts.22059

Brewin, C. R., Dalgleish, T., & Joseph, S. (1996). A dual representation theory of posttraumatic stress disorder. Psychological Review, 103(4), 670–686. https://doi.org/10.1037/0033-295X.103.4.670

Brewin, C. R., Gregory, J. D., Lipton, M., & Burgess, N. (2010). Intrusive images in psychological disorders: Characteristics, neural mechanisms, and treatment implications. Psychological Review, 117(1), 210–232. https://doi.org/10.1037/a0018113

Ehlers, A., & Clark, D. M. (2000). A cognitive model of posttraumatic stress disorder. Behaviour Research and Therapy, 38(4), 319–345. https://doi.org/10.1016/S0005-7967(99)00123-0

Foa, E. B., & Kozak, M. J. (1986). Emotional processing of fear: Exposure to corrective information. Psychological Bulletin, 99(1), 20–35. https://doi.org/10.1037/0033-2909.99.1.20

Foa, E. B., Huppert, J. D., & Cahill, S. P. (2006). Emotional processing theory: An update. In B. O. Rothbaum (Ed.), Pathological anxiety: Emotional processing in etiology and treatment (pp. 3–24). The Guilford Press.

King, D. W., Leskin, G. A., King, L. A., & Weathers, F. W. (1998). Confirmatory factor analysis of the Clinician-Administered PTSD Scale: Evidence for the dimensionality of posttraumatic stress disorder. Psychological Assessment, 10(2), 90–96. https://doi.org/10.1037/1040-3590.10.2.90

Simms, L. J., Watson, D., & Doebbeling, B. N. (2002). Confirmatory factor analyses of posttraumatic stress symptoms in deployed and nondeployed veterans of the Gulf War. Journal of Abnormal Psychology, 111(4), 637–647. https://doi.org/10.1037/0021-843X.111.4.637

Weathers, F. W., Bovin, M. J., Lee, D. J., Sloan, D. M., Schnurr, P. P., Kaloupek, D. G., Keane, T. M., & Marx, B. P. (2018). The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5): Development and initial psychometric evaluation in military veterans. Psychological Assessment, 30(3), 383–395. https://doi.org/10.1037/pas0000486

Weathers, F. W., Litz, B. T., Keane, T. M., Palmieri, P. A., Marx, B. P., & Schnurr, P. P. (2013). The PTSD Checklist for DSM-5 (PCL-5). Instrument available from the National Center for PTSD at www.ptsd.va.gov.

Wortmann, J. H., Jordan, A. H., Weathers, F. W., Resick, P. A., Dondanville, K. A., Hall-Clark, B., Foa, E. B., Young-McCaughan, S., Mintz, J., Peterson, A. L., & Litz, B. T. (2016). Psychometric analysis of the PTSD Checklist-5 (PCL-5) among treatment-seeking military service members. Psychological Assessment, 28(11), 1392–1403. https://doi.org/10.1037/pas0000260

Items of the Scale